With over 200 COVID-19 vaccines undergoing clinical trials or early-stage development, and the first vaccines now approved in the UK and Russia, the era of Vaccine Travel is about to unfold. It will bring a tangle of economic, political and social complications. Amid this nascent landscape, the travel industry is trying to forge a way ahead.
Already Qantas has said it will require passengers to be vaccinated, while Singapore Airlines and Garuda will be involved in vaccine logistics in South East Asia. Meanwhile, governments are sourcing a cocktail of vaccine supplies from East and West. But what happens when a single-dose vaccine finally gets approved? Will this change everything?
This week, Gary and Hannah analyse the current vaccine procurement situation in South East Asia and Asia Pacific, and look ahead to 2021, the Year of Vaccine Travelnomics.